Your session is about to expire
← Back to Search
Behavioural Intervention
ATTACH™ Parenting Program for Strengthening Parent-Child Relationships (ATTACH™ Trial)
N/A
Recruiting
Led By Nicole Letourneau, PhD RN
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline asq-3 scores immediately after completion of intervention and at 3 months.
Awards & highlights
No Placebo-Only Group
Summary
This trial will test an intervention program to help parents of young kids at risk of early adversity (e.g., family violence, parental depression, and low income) to strengthen parent-child relationships and improve child mental health.
Who is the study for?
This trial is for parents with children from birth to 32 months old, who are willing to participate in a 10-week online parenting program. The program includes one-hour weekly training sessions and encourages bringing a co-parent for two of the sessions if possible.
What is being tested?
The ATTACH™ Online Platform Parenting Program is being tested. It's designed to improve parent-child relationships and child development by enhancing parents' understanding of their own and their child's thoughts and feelings, especially after early adversity like family violence or parental depression.
What are the potential side effects?
Since this intervention involves an educational parenting program rather than medical treatment, traditional side effects are not applicable. However, participants may experience emotional discomfort or stress while engaging with the material or reflecting on personal experiences.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline pcits scores immediately after completion of intervention and at 3 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline pcits scores immediately after completion of intervention and at 3 months.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Children's Mental Health and Development
Secondary study objectives
Parent-Child Relationship Quality
Parental Reflective Function (RF)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: ATTACH™ Online Platform Parenting ProgramExperimental Treatment1 Intervention
A quasi-experimental design was selected to more closely approximate service delivery models in agencies that do not typically employ control groups.
Given promising findings (from seven ATTACH™ pilot studies), a randomized controlled trial design, even employing wait-list controls, was deemed unacceptable and even unethical by patients, healthcare professionals, and health system administrators in engagement activities surrounding the preparation of this proposal.
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
811 Previous Clinical Trials
889,416 Total Patients Enrolled
Nicole Letourneau, PhD RNPrincipal InvestigatorUniversity of Calgary
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a parent of a child who is between birth and 32 months old.I agree to join a 10-week online parent training program.I agree to bring a co-parent to 2 of the 10 sessions, if possible.
Research Study Groups:
This trial has the following groups:- Group 1: ATTACH™ Online Platform Parenting Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.